MedTrace Logo

Risk Markers of Arterial Aging. The Paris Prospective Study III-2

NCT06079424 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 7500

Last updated 2025-09-11

No results posted yet for this study

Summary

The main objectives of PPS3-2 are (i) to describe the dynamics of vascular aging and baroreflex sensitivity 12 to 16 years a part, (ii) to identify their determinants, and (iii) to quantify the subsequent risk of cardiovascular diseases.

Conditions

  • Arterial Stiffness

Interventions

OTHER

high-precision carotid echo-tracking

evaluation of vascular aging parameters and baroreflex sensitivity

Sponsors & Collaborators

  • Institut National de la Santé Et de la Recherche Médicale, France

    lead OTHER_GOV

Principal Investigators

  • Jean-Philippe Empana, MD, PhD · Institut National de la Santé Et de la Recherche Médicale, France

Eligibility

Min Age
60 Years
Max Age
95 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-06-20
Primary Completion
2031-05-31
Completion
2033-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06079424 on ClinicalTrials.gov